Clostridium difficile toxinotyping

Methods in Molecular Biology

Volumn 646, Issue , 2010, Pages 67-76

  Rupnik, Maja ^a,b  

^a Centre for Microbiology   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Clostridium difficile; PaLoc; toxin genes; toxinotype; variability; variant toxins

Indexed keywords

CLOSTRIDIUM DIFFICILE;

BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ARTICLE; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLOSTRIDIUM DIFFICILE; GENETICS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 79958024067     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-365-7_5     Document Type: Article

References (12)

1. Braun V, Hundesberger T, Leukel P, Sauerborn M and von Eichel-Streiber C. (1996) Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181, 29-38.
2. Rupnik M, Dupuy B, Fairweather NF, Gerding DN, Johnson S, Just I, Lyerly DM, Popoff MR, Rood JI, Sonenshein AL, Thelestam M, Wren BW, Wilkins TD and Eichel-Streiber CV. (2005) Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54, 113-117.
3. Borriello SP, Wren BW, Hyde S, Seddon SV, Sibbons P, Krishna MM, Tabaqchali S, Manek S and Price AB. (1992) Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60, 4192-4199.
4. Lyerly DM, Barroso LA, Wilkins TD, Depitre C and Corthier G. (1992) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60, 4633-4639.
5. Depitre C, Delmée M, Avesani V, LHaridon R, Roels A, Popoff M and Corthier G. (1993) Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol 38, 434-441.
6. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C and Delmée M. (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240-2247.
7. Rupnik M. (2008) Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32, 541-555.
8. Spigaglia P and Mastrantonio P. (2002) Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470-3475.
9. Curry SR, Marsh JW, Muto CA, OLeary MM, Pasculle AW and Harrison LH. (2007) tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45, 215-221.
10. Chaves-Olarte E, Freer E, Parra A, Guzman-Verri C, Moreno E and Thelestam M. (2003) R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile. J Biol Chem 278, 7956-7963.
11. Perelle S, Gibert M, Bourlioux P, Corthier G and Popoff MR. (1997) Production of a complete binary toxin (actinspecific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65, 1402-1407.
12. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B and Popoff M. (2000) Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186, 307-312.